{"bill": {"#text": "\n\t", "form": {"current-chamber": {"#tail": "\n\t\t", "#text": "IN THE HOUSE OF REPRESENTATIVES"}, "#text": "\n\t\t", "congress": {"#tail": "\n\t\t", "#text": "113th CONGRESS"}, "#tail": "\n\t", "legis-num": {"#tail": "\n\t\t", "#text": "H. R. 4709"}, "official-title": {"#tail": "\n\t", "#text": "To improve enforcement efforts related to prescription drug diversion and abuse, and for other\n\t\t\t purposes."}, "session": {"#tail": "\n\t\t", "#text": "2d Session"}, "distribution-code": {"#tail": "\n\t\t", "@display": "yes", "#text": "I"}, "action": {"action-date": {"#tail": "\n\t\t\t", "@date": "20140521", "#text": "May 21, 2014"}, "#tail": "\n\t\t", "action-desc": {"#tail": "\n\t\t", "#text": "\n        ", "committee-name": [{"#tail": ", and in addition to the Committee on the ", "@committee-id": "HIF00", "#text": "Committee on Energy and Commerce"}, {"#tail": ", for a period to be subsequently determined by the Speaker, in each case for consideration of such\n\t\t\t provisions as fall within the jurisdiction of the committee concerned", "@committee-id": "HJU00", "#text": "Judiciary"}], "sponsor": {"#tail": " (for himself, ", "#text": "Mr. Marino", "@name-id": "M001179"}, "cosponsor": [{"#tail": ", ", "#text": "Mrs. Blackburn", "@name-id": "B001243"}, {"#tail": ", and ", "#text": "Mr. Welch", "@name-id": "W000800"}, {"#tail": ") introduced the following bill; which was referred to the ", "#text": "Ms. Chu", "@name-id": "C001080"}]}, "#text": "\n\t\t\t"}, "legis-type": {"#tail": "\n\t\t", "#text": "A BILL"}}, "@bill-stage": "Introduced-in-House", "@bill-type": "olc", "@dms-id": "HEA367D0501F54DFE8B821C161D1C78A9", "@public-private": "public", "legis-body": {"#tail": "\n", "@style": "OLC", "section": [{"@section-type": "section-one", "#tail": "\n    ", "text": {"#tail": "\n\t\t", "quote": {"short-title": {"#tail": "\n        ", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": "\n          ", "@entity-type": "act", "#text": "Ensuring Patient Access and Effective Drug Enforcement Act of 2014", "@value": "Ensuring Patient Access and Effective Drug Enforcement Act of 2014", "@proposed": "true"}, "#text": "\n            "}, "#tail": ".", "#text": "\n          "}, "#text": "This Act may be cited as the ", "@display-inline": "no-display-inline"}, "enum": {"#tail": "\n      ", "#text": "1."}, "header": {"#tail": "\n      ", "#text": "Short title"}, "#text": "\n      ", "@id": "H1A3C234A6A3F4180915AF86882056194"}, {"#tail": "\n    ", "enum": {"#tail": "\n      ", "#text": "2."}, "header": {"#tail": "\n\t\t\t", "#text": "Registration process under Controlled Substances Act"}, "subsection": [{"#tail": "\n      ", "enum": {"#tail": "\n        ", "#text": "(a)"}, "header": {"#tail": "\n\t\t\t\t", "#text": "Definitions"}, "paragraph": [{"#tail": "\n        ", "text": {"#tail": "\n\t\t\t\t\t", "#text": "\n            ", "{http://namespaces.cato.org/catoxml}entity": {"#tail": " is amended by adding at the end the\n\t\t\t following:", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": " (", "@entity-type": "act", "#text": "Section 303 of the Controlled Substances Act", "@value": "Controlled Substances Act/s:303"}, "@entity-type": "law-citation", "#text": "\n              ", "external-xref": {"#tail": ")", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": "\n              ", "@entity-type": "uscode", "#text": "21 U.S.C. 823", "@value": "usc/21/823"}, "@parsable-cite": "usc/21/823", "#text": "\n                ", "@legal-doc": "usc"}}}, "enum": {"#tail": "\n          ", "#text": "(1)"}, "header": {"#tail": "\n          ", "#text": "Consistent with the public health and safety"}, "quoted-block": {"@style": "OLC", "after-quoted-block": {"#tail": "\n          ", "#text": "."}, "#tail": "\n\t\t\t\t", "subsection": {"#tail": "\n            ", "text": {"#tail": "\n            ", "quote": {"#tail": " means having a substantial relationship to this Act\u2019s purpose of preventing diversion and abuse of\n\t\t\t controlled substances.", "#text": "consistent with the public health and safety"}, "#text": "In this section, the phrase ", "@display-inline": "yes-display-inline"}, "enum": {"#tail": "\n              ", "#text": "(j)"}, "@id": "HE28889F9321B4D70A71D108F4ABE5AC8", "#text": "\n              "}, "@display-inline": "no-display-inline", "#text": "\n\t\t\t\t\t\t", "@id": "HC23ABE5D37C8466EAE9E17D77747E71E"}, "#text": "\n          ", "@id": "H0370E1D6A08C47EDB9469C9E40E80F5F"}, {"#tail": "\n      ", "@id": "H443A13BAB1724614B4ECAFDCE19ECCD8", "enum": {"#tail": "\n          ", "#text": "(2)"}, "header": {"#tail": "\n          ", "#text": "Imminent danger"}, "text": {"#tail": "\n\t\t\t\t\t", "#text": "\n            ", "{http://namespaces.cato.org/catoxml}entity": {"#tail": " is amended\u2014", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": " (", "@entity-type": "act", "#text": "Section 304(d) of the Controlled Substances Act", "@value": "Controlled Substances Act/s:304/ss:d"}, "@entity-type": "law-citation", "#text": "\n              ", "external-xref": {"#tail": ")", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": "\n              ", "@entity-type": "uscode", "#text": "21 U.S.C. 824(d)", "@value": "usc/21/824/d"}, "@parsable-cite": "usc/21/824", "#text": "\n                ", "@legal-doc": "usc"}}}, "#text": "\n          ", "subparagraph": [{"#tail": "\n          ", "text": {"#tail": "\n\t\t\t\t\t", "quote": [{"#tail": " and inserting ", "#text": "(d) The Attorney General"}, {"#tail": "; and", "#text": "(d)(1) The Attorney General"}], "#text": "by striking "}, "enum": {"#tail": "\n            ", "#text": "(A)"}, "@id": "H037E8677CDEE4ABBAB3BA33818469E4E", "#text": "\n            "}, {"#tail": "\n        ", "text": {"#tail": "\n\t\t\t\t\t\t", "#text": "by adding at the end the following:"}, "enum": {"#tail": "\n            ", "#text": "(B)"}, "quoted-block": {"@style": "OLC", "after-quoted-block": {"#tail": "\n            ", "#text": "."}, "#tail": "\n\t\t\t\t\t", "paragraph": {"@indent": "up1", "#tail": "\n              ", "text": {"#tail": "\n              ", "term": {"#tail": " means a significant and present risk of death or serious bodily harm that is more likely than not\n\t\t\t to occur in the absence of an immediate suspension order.", "#text": "imminent danger"}, "#text": "In this subsection, the term ", "@display-inline": "yes-display-inline"}, "enum": {"#tail": "\n                ", "#text": "(2)"}, "#text": "\n                ", "@id": "H6592CF50EB9D496AB6E7B49DC0D781B3"}, "@display-inline": "no-display-inline", "#text": "\n\t\t\t\t\t\t\t", "@id": "HED80E5E3A6764205894F08031973576D"}, "#text": "\n            ", "@id": "HBF5766243F734476A119A6AFE9AA7584"}]}], "#text": "\n        ", "@id": "H4EB98953CE494279B2FD203A93FFEFC7"}, {"#tail": "\n    ", "text": {"#tail": "\n\t\t\t\t", "#text": "\n          ", "{http://namespaces.cato.org/catoxml}entity": {"#tail": " is amended\u2014", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": " (", "@entity-type": "act", "#text": "Section 304(c) of the Controlled Substances Act", "@value": "Controlled Substances Act/s:304/ss:c"}, "@entity-type": "law-citation", "#text": "\n            ", "external-xref": {"#tail": ")", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": "\n            ", "@entity-type": "uscode", "#text": "21 U.S.C. 824(c)", "@value": "usc/21/824/c"}, "@parsable-cite": "usc/21/824", "#text": "\n              ", "@legal-doc": "usc"}}, "@display-inline": "yes-display-inline"}, "enum": {"#tail": "\n        ", "#text": "(b)"}, "header": {"#tail": "\n        ", "#text": "Opportunity To submit corrective action plan prior to revocation or suspension"}, "paragraph": [{"#tail": "\n        ", "text": {"#tail": "\n\t\t\t\t", "quote": [{"#tail": " and inserting ", "#text": "(c) Before"}, {"#tail": "; and", "#text": "(c)(1) Before"}], "#text": "by striking "}, "enum": {"#tail": "\n          ", "#text": "(1)"}, "@id": "H956C0DD8D9ED4FD19550497D8856FF6A", "#text": "\n          "}, {"#tail": "\n      ", "text": {"#tail": "\n\t\t\t\t\t", "#text": "by adding at the end the following:"}, "enum": {"#tail": "\n          ", "#text": "(2)"}, "quoted-block": {"@style": "OLC", "after-quoted-block": {"#tail": "\n          ", "#text": "."}, "#tail": "\n\t\t\t\t", "paragraph": {"@indent": "up1", "#tail": "\n            ", "text": {"#tail": "\n\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": [{"#tail": ", the ", "@entity-type": "act", "#text": "section 303", "@value": "Controlled Substances Act/s:303"}, {"#tail": " shall\u2014", "@entity-type": "federal-body", "#text": "Attorney General", "@entity-id": "1500"}], "#text": "Before revoking or suspending a registration pursuant to ", "@display-inline": "yes-display-inline"}, "enum": {"#tail": "\n              ", "#text": "(2)"}, "#text": "\n              ", "@id": "HF219B3BF3994423FB7475743E97DBE98", "subparagraph": [{"#tail": "\n              ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t", "#text": "provide\u2014", "@display-inline": "yes-display-inline"}, "enum": {"#tail": "\n                ", "#text": "(A)"}, "clause": [{"#tail": "\n                ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t", "#text": "notice to the registrant of the grounds for revocation or suspension; and"}, "enum": {"#tail": "\n                  ", "#text": "(i)"}, "@id": "H9C396F22141D4DD68423451F80345B6F", "#text": "\n                  "}, {"#tail": "\n              ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t", "#text": "in the case of any such grounds consisting of a violation of law, a specific citation to such law;"}, "enum": {"#tail": "\n                  ", "#text": "(ii)"}, "@id": "HE801358AE73945C7B04DC956526E2979", "#text": "\n                  "}], "#text": "\n                ", "@id": "H84E80B237D604876A695192524179377"}, {"#tail": "\n              ", "text": {"#tail": "\n\t\t\t\t\t\t\t", "#text": "give the registrant an opportunity to submit a corrective action plan within a reasonable period of\n\t\t\t time to demonstrate how the registrant plans to correct the grounds for\n\t\t\t revocation or suspension; and"}, "enum": {"#tail": "\n                ", "#text": "(B)"}, "@id": "H80D6EE276EAF4F208ED63B5BDFB12E7E", "#text": "\n                "}, {"#tail": "\n            ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t", "#text": "determine whether\u2014"}, "enum": {"#tail": "\n                ", "#text": "(C)"}, "clause": [{"#tail": "\n                ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t", "#text": "in light of the plan, revocation or suspension proceedings should be discontinued or deferred; or"}, "enum": {"#tail": "\n                  ", "#text": "(i)"}, "@id": "H378CE9AA98CC45FBB1F79B1083F44D25", "#text": "\n                  "}, {"#tail": "\n              ", "text": {"#tail": "\n                ", "#text": "additional changes need to be made in the corrective action plan."}, "enum": {"#tail": "\n                  ", "#text": "(ii)"}, "@id": "H86DB9FE2BC64447C973EA4C2BE887B25", "#text": "\n                  "}], "#text": "\n                ", "@id": "HFA7822B206BF4CDE81D4806C3EFA14A1"}]}, "@display-inline": "no-display-inline", "#text": "\n\t\t\t\t\t\t", "@id": "H6AC7CBF4B286487BB12E6DB4518CA348"}, "#text": "\n          ", "@id": "H220F20C5379948E6A45770A8E42E1FFD"}], "#text": "\n        ", "@id": "H01AF43FDA0544A5891C84C2D41E0F74B"}], "#text": "\n      ", "@id": "H4060093F474B4460B925E04FF2CDB367"}, {"#tail": "\n  ", "enum": {"#tail": "\n      ", "#text": "3."}, "header": {"#tail": "\n\t\t\t", "#text": "Report to Congress on effects of law enforcement activities on patient access to medications"}, "subsection": [{"#tail": "\n      ", "text": {"#tail": "\n\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": [{"#tail": ", acting through the ", "@entity-type": "federal-body", "#text": "Secretary of Health and Human\n\t\t\t Services", "@entity-id": "7500"}, {"#tail": " and the\n\t\t\t ", "@entity-type": "federal-body", "#text": "Commissioner of Food and Drugs", "@entity-id": "7524"}, {"#tail": ", and in\n\t\t\t consultation with the ", "@entity-type": "federal-body", "#text": "Director of the Centers for Disease Control and Prevention", "@entity-id": "7523"}, {"#tail": "\n\t\t\t and the ", "@entity-type": "federal-body", "#text": "Administrator of the Drug Enforcement Administration", "@entity-id": "1524"}, {"#tail": ", shall submit a report to\n\t\t\t the Congress\u2014", "@entity-type": "federal-body", "#text": "Director of National Drug Control Policy", "@entity-id": "1127"}], "#text": "Not later than one year after the date of enactment of this Act, the ", "@display-inline": "yes-display-inline"}, "enum": {"#tail": "\n        ", "#text": "(a)"}, "header": {"#tail": "\n        ", "#text": "In general"}, "paragraph": [{"#tail": "\n        ", "text": {"#tail": "\n\t\t\t\t", "#text": "assessing how patient access to medications could be adversely impacted by Federal and State law\n\t\t\t enforcement activities; and"}, "enum": {"#tail": "\n          ", "#text": "(1)"}, "@id": "H1EA96BC8B3C849B194E82FF66FAC86D9", "#text": "\n          "}, {"#tail": "\n      ", "text": {"#tail": "\n\t\t\t\t", "#text": "identifying how collaboration between agencies and stakeholders can benefit patients and prevent\n\t\t\t diversion and abuse of controlled substances."}, "enum": {"#tail": "\n          ", "#text": "(2)"}, "@id": "H97341524A9394C228233DE5C3E94A9F4", "#text": "\n          "}], "#text": "\n        ", "@id": "H1FC368A2150A4B75A00B35564B3B3EA5"}, {"#tail": "\n    ", "text": {"#tail": "\n\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": " shall incorporate feedback and recommendations from the following:", "@entity-type": "act", "#text": "subsection (a)", "@value": "Ensuring Patient Access and Effective Drug Enforcement Act of 2014/s:3/ss:a", "@proposed": "true"}, "#text": "The report under ", "@display-inline": "yes-display-inline"}, "enum": {"#tail": "\n        ", "#text": "(b)"}, "header": {"#tail": "\n        ", "#text": "Consultation"}, "paragraph": [{"#tail": "\n        ", "text": {"#tail": "\n\t\t\t\t", "#text": "Patient groups."}, "enum": {"#tail": "\n          ", "#text": "(1)"}, "@id": "H94C2CFF0AB8F4E5DB9276D016E6B9727", "#text": "\n          "}, {"#tail": "\n        ", "text": {"#tail": "\n\t\t\t\t", "#text": "Pharmacies."}, "enum": {"#tail": "\n          ", "#text": "(2)"}, "@id": "HD5B2D934E0B94E2DBE024AF816BEBD70", "#text": "\n          "}, {"#tail": "\n        ", "text": {"#tail": "\n\t\t\t\t", "#text": "Manufacturers of drugs."}, "enum": {"#tail": "\n          ", "#text": "(3)"}, "@id": "H6EA61D081A79404F9116785DC1DA7449", "#text": "\n          "}, {"#tail": "\n        ", "text": {"#tail": "\n\t\t\t\t", "#text": "Common or contract carriers and warehousemen."}, "enum": {"#tail": "\n          ", "#text": "(4)"}, "@id": "H8C70C2F24CE24B5A91AB1ED0B99C9806", "#text": "\n          "}, {"#tail": "\n        ", "text": {"#tail": "\n\t\t\t\t", "#text": "Hospitals, physicians, and other health care providers."}, "enum": {"#tail": "\n          ", "#text": "(5)"}, "@id": "HE71DBCE805E14D23A1EBDF3D4DF06209", "#text": "\n          "}, {"#tail": "\n        ", "text": {"#tail": "\n\t\t\t\t", "#text": "State attorneys general."}, "enum": {"#tail": "\n          ", "#text": "(6)"}, "@id": "H22777373DAD84350BA84457C14F5EE00", "#text": "\n          "}, {"#tail": "\n        ", "text": {"#tail": "\n\t\t\t\t", "#text": "Law enforcement officials, including local law enforcement officials."}, "enum": {"#tail": "\n          ", "#text": "(7)"}, "@id": "H491EB40AA18F4A76B6BACEF67FD1690F", "#text": "\n          "}, {"#tail": "\n        ", "text": {"#tail": "\n\t\t\t\t", "#text": "Health benefit plans and entities that provide pharmacy benefit management services on behalf of a\n\t\t\t health benefit plan."}, "enum": {"#tail": "\n          ", "#text": "(8)"}, "@id": "H3C55551E65F3487DB77033BBC119FFA7", "#text": "\n          "}, {"#tail": "\n      ", "text": {"#tail": "\n\t\t\t\t", "#text": "Wholesale drug distributors."}, "enum": {"#tail": "\n          ", "#text": "(9)"}, "@id": "H58AFF0710FC943F48919AB6E2D259531", "#text": "\n          "}], "#text": "\n        ", "@id": "HFC2A3FC57C8B43E9A761B737B4BA19E1"}], "#text": "\n      ", "@id": "HCEC36C4C60924DCA81E8A1F4CF6A15ED"}], "#text": "\n\t\t", "@id": "HAEF97E493D1940C693F84A1B5D02C1F7"}, "metadata": {"#tail": "\n", "dublinCore": {"{http://purl.org/dc/elements/1.1/}date": {"#tail": "\n", "#text": "2014-05-21"}, "{http://purl.org/dc/elements/1.1/}format": {"#tail": "\n", "#text": "text/xml"}, "{http://purl.org/dc/elements/1.1/}language": {"#tail": "\n", "#text": "EN"}, "#tail": "\n", "{http://purl.org/dc/elements/1.1/}title": {"#tail": "\n", "#text": "113 HR 4709 IH: Ensuring Patient Access and Effective Drug Enforcement Act of 2014"}, "{http://purl.org/dc/elements/1.1/}rights": {"#tail": "\n", "#text": "Pursuant to Title 17 Section 105 of the United States Code, this file is not subject to copyright protection and is in the public domain."}, "{http://purl.org/dc/elements/1.1/}publisher": {"#tail": "\n", "#text": "U.S. House of Representatives"}, "#text": "\n"}, "#text": "\n"}}}